Short answer
Prioritize the development of mHealth applications and devices that offer robust support for diabetes self-management, aiming for features that demonstrably improve key health metrics like HbA1c.
- Field
- Innovation & Design
- Source
- PLoS ONE (2017)
- Method
- Overview of Systematic Reviews
- Evidence
- Moderate effect
Mobile health (mHealth) interventions demonstrate a measurable positive impact on glycemic control in diabetes patients, particularly for Type 2 diabetes. This innovation & design research insight is drawn from a 2017 study published in PLoS ONE. Using Overview of systematic reviews, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Prioritize the development of mHealth applications and devices that offer robust support for diabetes self-management, aiming for features that demonstrably improve key health metrics like HbA1c.
mHealth Interventions Improve Diabetes Glycemic Control by up to 0.8% HbA1c
Mobile health (mHealth) interventions demonstrate a measurable positive impact on glycemic control in diabetes patients, particularly for Type 2 diabetes.
PLoS ONE · 2017
Key Findings
- 01mHealth interventions improve glycemic control (HbA1c) compared to standard care or other non-mHealth approaches.
- 02Improvements were up to 0.8% for patients with Type 2 diabetes and 0.3% for patients with Type 1 diabetes in the short-term (≤12 months).
- 03The quality of evidence from the included systematic reviews varied considerably and often had methodological limitations.
Application
Design takeaway
Prioritize the development of mHealth applications and devices that offer robust support for diabetes self-management, aiming for features that demonstrably improve key health metrics like HbA1c.
How to apply
Consider integrating features such as personalized feedback, medication reminders, diet tracking, and educational content within mHealth platforms for diabetes.
Project actions
- 01When designing an mHealth solution, clearly define the target user group (e.g., Type 1 vs. Type 2 diabetes).
- 02Consider how your design will measure and demonstrate improvements in health metrics like HbA1c.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Consolidates evidence from multiple systematic reviews, providing a broad overview.
- +Focuses on a significant and growing area of healthcare technology.
Limitations
The effectiveness might be short-term, and the quality of existing research is not always high, meaning results could change with more studies.
Reliability & validity
The reliability of the findings is moderate due to the variability in the quality of the included systematic reviews. Validity is supported by the consolidation of multiple studies, but the overall evidence base's limitations impact the certainty of the effect size.
Think critically
Given the limitations in the quality of evidence, how can designers ensure their mHealth solutions are robust and provide reliable benefits beyond short-term improvements?
Design Principles
"Digital health interventions can be effective tools for improving chronic disease management outcomes."
This finding highlights the potential of digital health solutions to enhance chronic disease management. Designers and engineers can leverage this insight to develop more effective mHealth tools that support patient self-management and improve health outcomes, potentially reducing healthcare system burdens.
What This Means for Your Design
Using apps and devices (mHealth) to help manage diabetes can make blood sugar levels better, especially for people with Type 2 diabetes.
How to use in your project
- 1.Reference this study to justify the potential impact of your mHealth design on patient health outcomes.
- 2.Use the findings to set realistic goals for the effectiveness of your proposed solution.
Add to My Project
Quick Cite
Paragraph starter
This research indicates that mHealth interventions can lead to clinically relevant improvements in glycemic control for diabetes patients, with observed reductions in HbA1c of up to 0.8% for Type 2 diabetes. This suggests a strong potential for well-designed digital health tools to support self-management and improve patient outcomes, a key consideration for any new design in this domain.
Source
PLoS ONE
Effectiveness of mHealth interventions for patients with diabetes: An overview of systematic reviews
journal · 2017
View sourceQuestions About This Research
- What does the research say about mhealth interventions improve diabetes glycemic control by up to 0.8% hba1c?
- Prioritize the development of mHealth applications and devices that offer robust support for diabetes self-management, aiming for features that demonstrably improve key health metrics like HbA1c. Evidence: PLoS ONE (2017).
- Why does "mHealth Interventions Improve Diabetes Glycemic Control by up to 0.8% HbA1c" matter for design?
- This finding highlights the potential of digital health solutions to enhance chronic disease management. Designers and engineers can leverage this insight to develop more effective mHealth tools that support patient self-management and improve health outcomes, potentially reducing healthcare system burdens.
- How can designers apply this research?
- Prioritize the development of mHealth applications and devices that offer robust support for diabetes self-management, aiming for features that demonstrably improve key health metrics like HbA1c.
- What were the main findings?
- mHealth interventions improve glycemic control (HbA1c) compared to standard care or other non-mHealth approaches.. Improvements were up to 0.8% for patients with Type 2 diabetes and 0.3% for patients with Type 1 diabetes in the short-term (≤12 months).. The quality of evidence from the included systematic reviews varied considerably and often had methodological limitations.
- What research method was used?
- Overview of Systematic Reviews.
- How strong is the evidence?
- Evidence strength is rated Moderate effect, based on a 2017 journal from PLoS ONE.
- What should I do differently in my next project?
- Consider integrating features such as personalized feedback, medication reminders, diet tracking, and educational content within mHealth platforms for diabetes.
- What are the limitations?
- The quality of the evidence base is variable, and many systematic reviews had methodological limitations, suggesting that future research may significantly alter these effect estimates.